These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 6328340)

  • 1. Immunological reaction of the demyelinating Semliki Forest virus with immune serum to glycolipids and its possible importance to central nervous system viral auto-immune disease.
    Webb HE; Mehta S; Gregson NA; Leibowitz S
    Neuropathol Appl Neurobiol; 1984; 10(2):77-84. PubMed ID: 6328340
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunoglobulin synthesis in nude (nu/nu), nu/+ and reconstituted nu/nu mice infected with a demyelinating strain of Semliki Forest virus.
    Suckling AJ; Jagelman S; Webb HE
    Clin Exp Immunol; 1982 Feb; 47(2):283-8. PubMed ID: 6280913
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunoelectron-microscopical labelling of glycolipids in the envelope of a demyelinating brain-derived RNA virus (Semliki Forest) by anti-glycolipid sera.
    Evans NR; Webb HE
    J Neurol Sci; 1986 Jul; 74(2-3):279-87. PubMed ID: 3016202
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CNS pathogenesis following a dual viral infection with Semliki Forest (alphavirus) and Langat (flavivirus).
    Amor S; Webb HE
    Br J Exp Pathol; 1988 Apr; 69(2):197-208. PubMed ID: 2837265
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Semliki Forest virus induced, immune mediated demyelination: the effect of irradiation.
    Fazakerley JK; Webb HE
    Br J Exp Pathol; 1987 Feb; 68(1):101-13. PubMed ID: 3028463
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Can viral envelope glycolipids produce auto-immunity, with reference to the CNS and multiple sclerosis?
    Webb HE; Fazakerley JK
    Neuropathol Appl Neurobiol; 1984; 10(1):1-10. PubMed ID: 6330601
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of immunoglobulin-containing cells in the central nervous system of the mouse following infection with the demyelinating strain of Semliki Forest virus.
    Parsons LM; Webb HE
    Br J Exp Pathol; 1989 Jun; 70(3):247-55. PubMed ID: 2548561
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunological relationship between a demyelinating RNA enveloped budding virus (Semliki Forest) and brain glycolipids.
    Khalili-Shirazi A; Gregson N; Webb HE
    J Neurol Sci; 1986 Nov; 76(1):91-103. PubMed ID: 3783190
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antisera to different glycolipids induce myelin alterations in mouse spinal cord tissue cultures.
    Roth GA; Röyttä M; Yu RK; Raine CS; Bornstein MB
    Brain Res; 1985 Jul; 339(1):9-18. PubMed ID: 4027618
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blood brain barrier disturbance and immunoglobulin G levels in the cerebrospinal fluid of the mouse following peripheral infection with the demyelinating strain of Semliki Forest virus.
    Parsons LM; Webb HE
    J Neurol Sci; 1982 Dec; 57(2-3):307-18. PubMed ID: 6298371
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Semliki Forest virus-induced, immune-mediated demyelination: adoptive transfer studies and viral persistence in nude mice.
    Fazakerley JK; Webb HE
    J Gen Virol; 1987 Feb; 68 ( Pt 2)():377-85. PubMed ID: 3029281
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Semliki Forest virus (A7[74]) infection of adult mice induces an immune-mediated demyelinating encephalomyelitis.
    Fazakerley JK; Khalili-Shirazi A; Webb HE
    Ann N Y Acad Sci; 1988; 540():672-3. PubMed ID: 2849913
    [No Abstract]   [Full Text] [Related]  

  • 13. Replication of the A7(74) strain of Semliki Forest virus is restricted in neurons.
    Fazakerley JK; Pathak S; Scallan M; Amor S; Dyson H
    Virology; 1993 Aug; 195(2):627-37. PubMed ID: 8393239
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inflammatory neuropathies.
    Hughes RA
    Baillieres Clin Neurol; 1994 Apr; 3(1):45-72. PubMed ID: 7921591
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The pathogenicity of the M9 mutant of Semliki Forest virus in immune-compromised mice.
    Gates MC; Sheahan BJ; Atkins GJ
    J Gen Virol; 1984 Jan; 65 ( Pt 1)():73-80. PubMed ID: 6319575
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reconstitution of Semliki forest virus infected mice, induces immune mediated pathological changes in the CNS.
    Fazakerley JK; Amor S; Webb HE
    Clin Exp Immunol; 1983 Apr; 52(1):115-20. PubMed ID: 6305540
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of mouse strain on the pathogenesis of the encephalitis and demyelination induced by avirulent Semliki Forest virus infections.
    Suckling AJ; Jagelman S; Illavia SJ; Webb HE
    Br J Exp Pathol; 1980 Jun; 61(3):281-4. PubMed ID: 6252935
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Monoclonal IgM autoantibody activity vis-à-vis glycoconjugates of peripheral nerves: apropos of 112 cases].
    Caudie C; Vial C; Petiot P; Bancel J; Lombard C; Gonnaud PM
    Ann Biol Clin (Paris); 2001; 59(5):567-77. PubMed ID: 11602387
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The pathogenicity of the A7, M9 and L10 strains of Semliki Forest virus for weanling mice and primary mouse brain cell cultures.
    Gates MC; Sheahan BJ; O'Sullivan MA; Atkins GJ
    J Gen Virol; 1985 Nov; 66 ( Pt 11)():2365-73. PubMed ID: 2997371
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Virus tropism, distribution, persistence and pathology in the corpus callosum of the Semliki Forest virus-infected mouse brain: a novel system to study virus-oligodendrocyte interactions.
    Fazakerley JK; Cotterill CL; Lee G; Graham A
    Neuropathol Appl Neurobiol; 2006 Aug; 32(4):397-409. PubMed ID: 16866985
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.